Mandate

Vinge has advised Sparbanken Skåne

August 14, 2017

Vinge acted as legal adviser in connection with Sparbanken Skåne AB (publ)’s (”Sparbanken Skåne”) establishment of a programme for the issuance of covered bonds in accordance with the Swedish Covered Bonds Issuance Act (SFS 2003:1223).

The programme enables Sparbanken Skåne to continuously issue notes in SEK within a maximum outstanding nominal amount of SEK 30 billion at each time. The borrowing through covered bonds will enable Sparbanken Skåne to increase its presence on the capital market and to diversify its borrowing.

Vinge’s team consisted of partner Louise Brorsson Salomon together with amongst others Josefine Larsson, André Isacson, Lionardo Ojeda and Sara Osman.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025